国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2011年
10期
729-732
,共4页
树突细胞%癌症疫苗%SOCS1
樹突細胞%癌癥疫苗%SOCS1
수돌세포%암증역묘%SOCS1
Dendritic cells%Cancer vaccines%SOCS1
在肿瘤疫苗中树突状细胞(DC)是启动抗肿瘤免疫的主要辅助细胞.细胞因子信号抑制因子l (SOCS1)对细胞因子信号转导具有抑制作用.最近的研究表明,抑制DC中SOCS1的功能对提高肿瘤疫苗的抗肿瘤活性具有重要作用,并且在如何抑制其功能的方法上也取得了重大进展.
在腫瘤疫苗中樹突狀細胞(DC)是啟動抗腫瘤免疫的主要輔助細胞.細胞因子信號抑製因子l (SOCS1)對細胞因子信號轉導具有抑製作用.最近的研究錶明,抑製DC中SOCS1的功能對提高腫瘤疫苗的抗腫瘤活性具有重要作用,併且在如何抑製其功能的方法上也取得瞭重大進展.
재종류역묘중수돌상세포(DC)시계동항종류면역적주요보조세포.세포인자신호억제인자l (SOCS1)대세포인자신호전도구유억제작용.최근적연구표명,억제DC중SOCS1적공능대제고종류역묘적항종류활성구유중요작용,병차재여하억제기공능적방법상야취득료중대진전.
Dendritic cells (DCs) are the important auxiliary cells in tumor vaccines to activate antitumor immunity.Suppressor of cytokine signaling 1 ( SOCS1 ) has been shown to play an important role in inhibition of cytokine signal transduction.Recent studies show that inhibition of the function of SOCS1 in DCs plays a critical role in strongly enhancing tumor vaccines antitumor activity,and in the methods of restraining SOCS1 's function have also made significant progress.